75 F
Pakistan
Wednesday, June 3, 2026
HomeHealthKelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at...

Kelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at ASCO 2026

CHENGDU, China, June 3, 2026 /PRNewswire/ — Sichuan Kelun-Biotech Biopharmaceutical Co. , Ltd. (“Kelun-Biotech” or the “Company”, 6990. HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, the first-in-human study results of the. ..

Read full story on Pr Newswire Apac

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -
Google search engine

Most Popular

Recent Comments